Our findings deepen the understanding of the molecular pathogenesis of thyroid diseases and, via DSigDB, predict candidate drugs targeting the phosphodiesterase family (e.g., PDE8B, PDE10A), offering preclinical rationale for developing “precision-targeted, bidirectional regulatory” therapeutic strategies. This evidence concerns the gene PDE8B and thyroiditis.